DrugPatentWatch Database Preview
Auranofin - Generic Drug Details
What are the generic sources for auranofin and what is the scope of auranofin patent protection?
Auranofin
is the generic ingredient in one branded drug marketed by Sebela Ireland Ltd and is included in one NDA. Additional information is available in the individual branded drug profile pages.There are seven drug master file entries for auranofin. Two suppliers are listed for this compound.
Summary for auranofin
| US Patents: | 0 |
| Tradenames: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Drug Master File Entries: | 7 |
| Suppliers / Packagers: | 2 |
| Bulk Api Vendors: | 15 |
| Clinical Trials: | 12 |
| Patent Applications: | 2 |
| Formulation / Manufacturing: | see details |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for auranofin |
| DailyMed Link: | auranofin at DailyMed |
Medical Subject Heading (MeSH) Categories for auranofin
Synonyms for auranofin
| (1-Thio-.beta.-D-glucopyranosato)(triethylphosphine)gold 2,3,4,6-tetraacetate |
| [1-(Thio-|ES)-|A-D-glucopyranose 2,3,4,6-tetraacetato](triethylphosphine)gold |
| 34031-32-8 |
| 4-(2-aminoethyl)benzene sulfonyl fluoride hydrochloride |
| AC1OCFGC |
| AKOS026750078 |
| B7687 |
| CA003139 |
| CA009493 |
| CTK8F7877 |
| D0L2UN |
| FT-0662343 |
| Gold, (1-thio-.beta.-D-glucopyranosato)(triethylphosphine)-, 2,3,4,6-tetraacetate |
| GOLD(1+) ION [3,4,5-TRIS(ACETYLOXY)-6-[(ACETYLOXY)METHYL]OXAN-2-YL]SULFANIDE TRIETHYLPHOSPHINE |
| gold(1+); (2S,3R,4S,5R,6R)-3,4,5-triacetyloxy-6-(acetyloxymethyl)oxane-2-thiolate; triethylphosphane |
| KS-00001FB9 |
| MMV688978 |
| Ridaura (TN) |
| Ridauran |
| SCHEMBL5188854 |
| SK&F 39162 |
| SK&F-39162 |
US Patents and Regulatory Information for auranofin
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sebela Ireland Ltd | RIDAURA | auranofin | CAPSULE;ORAL | 018689-001 | May 24, 1985 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Expired US Patents for auranofin
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Sebela Ireland Ltd | RIDAURA | auranofin | CAPSULE;ORAL | 018689-001 | May 24, 1985 | ➤ Sign Up | ➤ Sign Up |
| Sebela Ireland Ltd | RIDAURA | auranofin | CAPSULE;ORAL | 018689-001 | May 24, 1985 | ➤ Sign Up | ➤ Sign Up |
| Sebela Ireland Ltd | RIDAURA | auranofin | CAPSULE;ORAL | 018689-001 | May 24, 1985 | ➤ Sign Up | ➤ Sign Up |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
